PL3436074T3 - Związki z grupą tiazolidynową do leczenia zakażeń wirusowych - Google Patents

Związki z grupą tiazolidynową do leczenia zakażeń wirusowych

Info

Publication number
PL3436074T3
PL3436074T3 PL17716741T PL17716741T PL3436074T3 PL 3436074 T3 PL3436074 T3 PL 3436074T3 PL 17716741 T PL17716741 T PL 17716741T PL 17716741 T PL17716741 T PL 17716741T PL 3436074 T3 PL3436074 T3 PL 3436074T3
Authority
PL
Poland
Prior art keywords
viral infections
treating viral
thiazolide compounds
thiazolide
compounds
Prior art date
Application number
PL17716741T
Other languages
English (en)
Inventor
Jean-Francois Rossignol
Maria Gabriella Santoro
Original Assignee
Romark Laboratories, L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romark Laboratories, L.C. filed Critical Romark Laboratories, L.C.
Publication of PL3436074T3 publication Critical patent/PL3436074T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL17716741T 2016-03-31 2017-03-30 Związki z grupą tiazolidynową do leczenia zakażeń wirusowych PL3436074T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662316463P 2016-03-31 2016-03-31
PCT/US2017/024976 WO2017173056A1 (en) 2016-03-31 2017-03-30 Thiazolide compounds for treating viral infections
EP17716741.8A EP3436074B1 (en) 2016-03-31 2017-03-30 Thiazolide compounds for treating viral infections

Publications (1)

Publication Number Publication Date
PL3436074T3 true PL3436074T3 (pl) 2020-11-02

Family

ID=58530692

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17716741T PL3436074T3 (pl) 2016-03-31 2017-03-30 Związki z grupą tiazolidynową do leczenia zakażeń wirusowych

Country Status (26)

Country Link
US (2) US11135202B2 (pl)
EP (2) EP3436074B1 (pl)
JP (2) JP6567781B2 (pl)
KR (3) KR102233826B1 (pl)
CN (1) CN108289961A (pl)
AU (2) AU2017244145B2 (pl)
BR (1) BR112018069974A2 (pl)
CA (2) CA3113354A1 (pl)
CY (1) CY1123221T1 (pl)
DK (1) DK3436074T3 (pl)
EA (2) EA036505B1 (pl)
ES (1) ES2810303T3 (pl)
HK (1) HK1250945A1 (pl)
HR (1) HRP20201261T1 (pl)
HU (1) HUE050601T2 (pl)
IL (2) IL262018A (pl)
LT (1) LT3436074T (pl)
MX (1) MX2021004464A (pl)
PH (1) PH12018502058A1 (pl)
PL (1) PL3436074T3 (pl)
PT (1) PT3436074T (pl)
SG (1) SG11201808453UA (pl)
SI (1) SI3436074T1 (pl)
UA (1) UA126114C2 (pl)
WO (1) WO2017173056A1 (pl)
ZA (1) ZA201806644B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111012778B (zh) * 2018-10-10 2022-06-24 北京市农林科学院 Nitazoxanide在抑制犬细小病毒中的应用
CN109536460A (zh) * 2018-12-07 2019-03-29 中国医学科学院医学生物学研究所 一种cv-a10病毒毒种及其人用灭活疫苗
CN110787161B (zh) * 2019-09-19 2022-09-27 中山大学 噻唑类化合物用于抗鱼类病毒的新用途
CN111012788B (zh) * 2019-12-12 2021-01-15 武汉职业技术学院 硝唑尼特和替唑尼特在制备抗猪繁殖与呼吸综合征病毒药物中的应用
EP4182304A1 (en) 2020-07-20 2023-05-24 Romark Laboratories, L.C. Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
AU2021333566A1 (en) 2020-08-24 2023-03-16 Romark Laboratories L.C. Use of thiazolides against coronaviruses
EP4337200A1 (en) * 2021-05-28 2024-03-20 Henderson, Theodore Treatment using an antiviral compound and nitazoxanide
WO2023040990A1 (zh) 2021-09-15 2023-03-23 南京强新生物医药有限公司 治疗冠状病毒感染的新联用药物、药物组合物及其用途
CN114404439B (zh) * 2022-02-11 2023-07-11 山东农业大学 抑制不同类型猪繁殖与呼吸综合症病毒感染的阻断剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US5387598A (en) 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5965590A (en) 1994-09-08 1999-10-12 Romark Lab Lc Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en) 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
MX9604483A (es) 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US5856348A (en) 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5935591A (en) 1998-01-15 1999-08-10 Romark Laboratories, L.C. Method for treatment of equine protozoal myeloencephalitis with thiazolides
CA2522007A1 (en) 2003-04-11 2004-10-28 Medimmune, Inc. Methods of preventing or treating respiratory conditions
UA90864C2 (en) 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
US8633230B2 (en) 2006-01-09 2014-01-21 Jean-Francois Rossignol Viral hepatitis treatment
BRPI0815057B8 (pt) 2007-08-03 2021-05-25 Romark Laboratories Lc composto, composição farmacêutica, e, uso de um composto
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
EA029018B1 (ru) 2009-02-13 2018-01-31 Ромарк Лабораториз Л.С. Фармацевтические составы нитазоксанида с контролируемым высвобождением
AP3074A (en) * 2009-05-12 2014-12-31 Romark Lab Lc Haloalkyl heteroaryl benzamide compounds
JP5932640B2 (ja) 2009-06-26 2016-06-08 ロマーク ラボラトリーズ エル.シー. インフルエンザを治療するための化合物および方法
EP2585067B1 (en) * 2010-06-25 2017-08-09 Biota Scientific Management Pty Ltd Compound for the treatment of enteroviruses
NZ611410A (en) 2010-11-01 2016-02-26 Romark Lab Lc Alkylsulfinyl-substituted thiazolide compounds
EA024063B1 (ru) 2011-05-16 2016-08-31 Ромарк Лабораториз Л.С. Способ стимуляции иммунного ответа путем введения тиазолидных соединений
WO2013136495A1 (ja) 2012-03-15 2013-09-19 トヨタ自動車株式会社 車両走行制御装置
KR102314960B1 (ko) * 2013-10-11 2021-10-19 얀센 바이오파마, 인코퍼레이트. 치환된 뉴클레오사이드, 뉴클레오타이드 및 이의 유사체
WO2016044656A1 (en) * 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
US10100023B2 (en) 2014-11-11 2018-10-16 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof

Also Published As

Publication number Publication date
CA3113354A1 (en) 2017-10-05
ES2810303T3 (es) 2021-03-08
IL262018A (en) 2018-10-31
JP2019203014A (ja) 2019-11-28
LT3436074T (lt) 2020-09-25
KR20210035339A (ko) 2021-03-31
EA201891975A1 (ru) 2019-03-29
US20220125767A1 (en) 2022-04-28
JP2019510044A (ja) 2019-04-11
EP3677282A1 (en) 2020-07-08
DK3436074T3 (da) 2020-08-03
CA3019326A1 (en) 2017-10-05
PT3436074T (pt) 2020-08-21
EP3436074A1 (en) 2019-02-06
EA036505B1 (ru) 2020-11-18
KR20180125552A (ko) 2018-11-23
AU2017244145A1 (en) 2018-11-15
HRP20201261T1 (hr) 2021-02-05
US20170281603A1 (en) 2017-10-05
JP6567781B2 (ja) 2019-08-28
SI3436074T1 (sl) 2020-09-30
BR112018069974A2 (pt) 2019-01-29
CN108289961A (zh) 2018-07-17
MX2021004464A (es) 2021-06-04
HUE050601T2 (hu) 2020-12-28
SG11201808453UA (en) 2018-10-30
EP3436074B1 (en) 2020-06-10
HK1250945A1 (zh) 2019-01-18
IL280327A (en) 2021-03-01
WO2017173056A1 (en) 2017-10-05
CA3019326C (en) 2021-05-25
EA202091849A1 (ru) 2020-12-11
KR102233826B1 (ko) 2021-03-31
KR102136803B1 (ko) 2020-07-22
AU2019236602A1 (en) 2019-10-17
ZA201806644B (en) 2021-02-24
US11135202B2 (en) 2021-10-05
KR20180124970A (ko) 2018-11-21
UA126114C2 (uk) 2022-08-17
CY1123221T1 (el) 2021-10-29
PH12018502058A1 (en) 2019-06-24
AU2017244145B2 (en) 2019-08-01

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
HK1258795A1 (zh) 絲狀病毒科病毒感染的治療方法
IL280327A (en) Thiazolide compounds for the treatment of viral infections
HUE058737T2 (hu) Eljárások arenaviridae vírusok okozta fertõzések kezelésére
IL256327A (en) Pharmacological preparations for the treatment of viral problems of the eye
EP3324987A4 (en) Bacteriophage for treating staphylococcus infections
HK1246682A1 (zh) 含有ala類的病毒感染症預防/治療劑
LT3471732T (lt) Liposomos, skirtos virusinių infekcijų gydymui
PL3131890T3 (pl) Związki do leczenia zakażeń wirusowych
IL249616A0 (en) Methods for treating inflammation
GB201611045D0 (en) Compounds for treating trypanosomal infections
TH1501004481A (th) อนุพันธ์ 2-อะมิโนไพริมิดีนเพื่อบำบัดการติดเชื้อไวรัส
AU2014901885A0 (en) Compounds for the treatment of antibacterial infections